Vor Biopharma Statistics

Total Valuation

Vor Biopharma has a market cap or net worth of $54.67 million. The enterprise value is $24.63 million.

Market Cap	54.67M
Enterprise Value	24.63M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Vor Biopharma has 68.67 million shares outstanding. The number of shares has increased by 10.66% in one year.

Current Share Class	68.67M
Shares Outstanding	68.67M
Shares Change (YoY)	+10.66%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	1.25%
Owned by Institutions (%)	27.72%
Float	38.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.75
P/TBV Ratio	0.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.45.

Current Ratio	4.69
Quick Ratio	4.38
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -90.79% and return on invested capital (ROIC) is -46.50%.

Return on Equity (ROE)	-90.79%
Return on Assets (ROA)	-43.51%
Return on Capital (ROIC)	-46.50%
Revenue Per Employee	n/a
Profits Per Employee	-$669,423
Employee Count	168
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.50% in the last 52 weeks. The beta is -0.41, so Vor Biopharma's price volatility has been lower than the market average.

Beta (5Y)	-0.41
52-Week Price Change	-54.50%
50-Day Moving Average	0.78
200-Day Moving Average	1.31
Relative Strength Index (RSI)	45.05
Average Volume (20 Days)	612,644

Short Selling Information

The latest short interest is 1.37 million, so 1.99% of the outstanding shares have been sold short.

Short Interest	1.37M
Short Previous Month	1.71M
Short % of Shares Out	1.99%
Short % of Float	3.56%
Short Ratio (days to cover)	2.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-118.00M
Pretax Income	-118.09M
Net Income	-112.46M
EBITDA	-114.44M
EBIT	-118.00M
Earnings Per Share (EPS)	-$1.65

Full Income Statement

Balance Sheet

The company has $62.81 million in cash and $32.85 million in debt, giving a net cash position of $29.96 million or $0.44 per share.

Cash & Cash Equivalents	62.81M
Total Debt	32.85M
Net Cash	29.96M
Net Cash Per Share	$0.44
Equity (Book Value)	72.96M
Book Value Per Share	1.06
Working Capital	52.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$99.62 million and capital expenditures -$268,000, giving a free cash flow of -$99.89 million.

Operating Cash Flow	-99.62M
Capital Expenditures	-268,000
Free Cash Flow	-99.89M
FCF Per Share	-$1.45

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vor Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.66%
Shareholder Yield	-10.66%
Earnings Yield	-212.65%
FCF Yield	-188.88%

Analyst Forecast

The average price target for Vor Biopharma is $11.36, which is 1,326.96% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.36
Price Target Difference	1,326.96%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.03%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1